<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Flow cytometric identification of small numbers of precursor B-cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) cells in post-treatment marrow specimens could benefit from the identification of additional, easily detectable markers that could be used in most cases </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we evaluate whether bcl-2 expression quantified by four-colour flow cytometry can be effectively used to discriminate precursor <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> blasts from <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell precursors (haematogones) and function as a <z:mpath ids='MPATH_336'>leukaemia</z:mpath>-specific marker </plain></SENT>
<SENT sid="2" pm="."><plain>Levels of bcl-2 in the 22 precursor <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cases studied were found to be significantly higher (over sixfold higher on average) than those present in haematogone populations from 22 control marrow specimens </plain></SENT>
<SENT sid="3" pm="."><plain>Higher relative levels of bcl-2 expression in the <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cases were maintained with respect to both immature CD34+ and more mature CD34- haematogone subsets, and appeared stable </plain></SENT>
<SENT sid="4" pm="."><plain>Dilutional studies indicated that multiparameter flow cytometry analysis using bcl-2 could identify precursor <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> blasts representing as few as 1% of CD19+ cells or 0.01% of total leucocytes in bone marrow specimens containing substantial numbers of haematogones </plain></SENT>
<SENT sid="5" pm="."><plain>This study suggests that bcl-2 may be an important marker for flow cytometric detection and quantification of small numbers of residual precursor <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> cells in bone marrow specimens </plain></SENT>
</text></document>